Avenue Therapeutics, Inc.
ATXI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001644963
No open-market purchases or sales by Avenue Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Avenue Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −8 vs. Q2 2022
- Shares held
- 75.9K
- +31.0K (+68.8%) vs. Q2 2022Converted for a 1-for-15 split
- Total value
- $766.0K
- +$585.0K (+323.2%) vs. Q2 2022
- New holders
- 4
- 3 more added
- Sold out
- 12
- 2 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATXI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 7 | $385.3K |
| Q3 2024 | 8 | $491.8K |
| Q2 2024 | 9 | $407.2K |
| Q1 2024 | 14 | $168.9K |
| Q4 2023 | 15 | $52.4K |
| Q3 2023 | 14 | $157.3K |
| Q2 2023 | 12 | $849.4K |
| Q1 2023 | 14 | $532.7K |
| Q4 2022 | 14 | $520.5K |
| Q3 2022 | 11 | $766.0K |
| Q2 2022 | 19 | $181.0K |
| Q1 2022 | 17 | $503.0K |
| Q4 2021 | 18 | $2.14M |
| Q3 2021 | 21 | $1.62M |
| Q2 2021 | 29 | $2.88M |
| Q1 2021 | 34 | $11.1M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Avenue Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 35,865 | $362.0K | 0.00% | +35,865 | New |
| Two Sigma Investments, LP | 14,342 | $145.0K | 0.00% | +14,342 | New |
| Two Sigma Securities, LLC | 14,159 | $143.0K | 0.02% | +12,415+712.0% | AddedConverted for a 1-for-15 split |
| Wells Fargo & Company | 4,538 | $46.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| BlackRock Inc. | 1,941 | $20.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Morgan Stanley | 1,474 | $15.0K | 0.00% | +1,474 | New |
| Tower Research Capital LLC (TRC) | 1,425 | $14.0K | 0.00% | +1,216+581.8% | AddedConverted for a 1-for-15 split |
| UBS Group AG | 1,138 | $11.0K | 0.00% | −985−46.4% | ReducedConverted for a 1-for-15 split |
| Emfo, LLC | 533 | $5.00K | 0.00% | −534−50.0% | ReducedConverted for a 1-for-15 split |
| Citigroup Inc | 510 | $5.00K | 0.00% | +477+1,430.0% | AddedConverted for a 1-for-15 split |
| Bank of America Corp | 1 | $0 | 0.00% | +1 | New |
| Vanguard Group Inc | 0 | $0 | 0.00% | −8,771−100.0% | Sold outConverted for a 1-for-15 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −8,293−100.0% | Sold outConverted for a 1-for-15 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −5,602−100.0% | Sold outConverted for a 1-for-15 split |
| National Asset Management, Inc. | 0 | $0 | 0.00% | −3,889−100.0% | Sold outConverted for a 1-for-15 split |
| HRT Financial LP | 0 | $0 | 0.00% | −2,607−100.0% | Sold outConverted for a 1-for-15 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −1,714−100.0% | Sold outConverted for a 1-for-15 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −918−100.0% | Sold outConverted for a 1-for-15 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −750−100.0% | Sold outConverted for a 1-for-15 split |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −759−100.0% | Sold outConverted for a 1-for-15 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-15 split |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-15 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −9−100.0% | Sold outConverted for a 1-for-15 split |